Skandinaviska Enskilda Banken Ab (Publ) Exelixis, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$21.5 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $402,325 - $504,317	20,900 Added 25.15%	104,005 $2.5 Million
Q1 2023 May 11, 2023	SELL	$16.3 - $19.41 $66,536 - $79,231	-4,082 Reduced 4.68%	83,105 $1.61 Million
Q4 2022 Feb 08, 2023	SELL	$14.96 - $17.39 $75,592 - $87,871	-5,053 Reduced 5.48%	87,187 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $538,749 - $765,174	34,359 Added 59.36%	92,240 $1.45 Million
Q4 2021 Feb 10, 2022	SELL	$15.84 - $21.88 $504,551 - $696,943	-31,853 Reduced 35.5%	57,881 $1.08 Million
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $646,555 - $838,539	-39,666 Reduced 30.65%	89,734 $1.9 Million
Q4 2020 Feb 11, 2021	SELL	$18.39 - $24.8 $23,907 - $32,240	-1,300 Reduced 0.99%	129,400 $2.6 Million
Q2 2020 Aug 13, 2020	SELL	$16.46 - $27.42 $126,742 - $211,134	-7,700 Reduced 5.56%	130,700 $3.1 Million
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $581,292 - $876,360	-40,200 Reduced 22.51%	138,400 $2.38 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $398,445 - $496,807	-26,300 Reduced 12.84%	178,600 $3.15 Million
Q3 2019 Nov 08, 2019	SELL	$17.68 - $22.65 $84,864 - $108,720	-4,800 Reduced 2.29%	204,900 $3.62 Million
Q2 2019 Aug 09, 2019	SELL	$18.93 - $24.75 $848,064 - $1.11 Million	-44,800 Reduced 17.6%	209,700 $4.48 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $178,360 - $225,316	9,100 Added 3.71%	254,500 $6.06 Million
Q4 2018 Feb 12, 2019	BUY	$13.65 - $21.8 $101,010 - $161,320	7,400 Added 3.11%	245,400 $4.83 Million
Q3 2018 Nov 05, 2018	BUY	$15.87 - $22.4 $165,048 - $232,959	10,400 Added 4.57%	238,000 $4.22 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $4.22 Million - $5.11 Million	227,600 New	227,600 $4.9 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account